Back

Towards a prognostically meaningful definition of non-dilated left ventricular cardiomyopathy

17 May 2025 (10:00 - 10:45)
Organised by: Logo
Congress Presentation Part of: Diagnosis and prognosis in cardiomyopathies and valvular disease Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Alberto Aimo

Sant'Anna School of Advanced Studies, Pisa (Italy)

4 More presentations in this session

Presentation thumbnail
Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: the role of overlap with arrhythmogenic cardiomyopathy
Doctor A. Aimo (Pisa, IT)
Abstract Slides Video
Presentation thumbnail
Prevalence and prognostic impact of aortic stenosis in wild-type transthyretin cardiac amyloidosis
Mr H. Malerbi (Toulouse, FR)
Abstract Slides Video
Presentation thumbnail
Relation of reduced left ventricular global longitudinal strain with exercise pulmonary hypertension and clinical implication in rheumatic mitral stenosis
Doctor S. Lee (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Predictors of right ventricular dysfunction in patients with surgical repair of Tetralogy of Fallot - significance of biomarkers
Assistant Professor E. Begic (Sarajevo, BA)
Abstract Slides Video

Access the full session

Session thumbnail
Diagnosis and prognosis in cardiomyopathies and valvular disease

The Event

Event poster

Heart Failure 2025

17 May 2025 10:00 CET
You may be interested in
thumbnail
Congress Presentation
Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: the role of overlap with arrhythmogenic cardiomyopathy
thumbnail
Congress Presentation
Cardiac magnetic resonance-based phenotyping, genetic architecture, and outcomes in dilated and non-dilated left ventricular cardiomyopathy
thumbnail
Congress Presentation
Non-dilated left ventricular cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources